Clinical Trial Update: Contrast Nephropathy Prevention With N-Acetylcysteine in Acute Myocardial Infarction [Phase 2, Phase 3]

View source ↗

Summary

The document notes the completion of Phase 2 and Phase 3 clinical trials evaluating N-acetylcysteine for preventing contrast-induced nephropathy in patients wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contrast-induced Nephropathy
• Myocardial Infarction

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: University of Milan | Conditions: Contrast-Induced Nephropathy, Acute Myocardial Infarction | Phase 2, Phase 3 | Status: COMPLETED